News

CPI Card Group, Cypris Materials Recognized with a Sustainability Initiative of the Year Award

CPI Card Group Inc. (Nasdaq: PMTS), a payment technology company providing a range of credit, debit and prepaid solutions, complementary digital solut

RadTech Announces 2024 Sustainability Award Winners

This year's winners have demonstrated various benefits, including energy savings, CO2 reductions, minimized water usage, and a significant decrease in VOC and hazardous air pollutant emissions. Moreover, they've streamlined supply chains, reduced transportation costs, and slashed waste through recyclability and material substitution.

Zeon Ventures Inc. on LinkedIn: Zeon Invests in Battery Technology Company Coreshell

Zeon Ventures is pleased to announce our investment in Coreshell Technologies.

This battery startup says it's found a way to make cheap LFP batteries without sacrificing range | TechCrunch

Coreshell, a battery materials startup, revealed a breakthrough this week that could lower the cost of lithium-ion batteries while reducing reliance on China.

Ferroglobe & Coreshell Sign a Memorandum of Understanding to Deliver World’s First Battery-Grade Metallurgical Silicon for Electric Vehicles

Ferroglobe & Coreshell Sign a Memorandum of Understanding to Deliver World’s First Battery-Grade Metallurgical Silicon for Electric Vehicles...

La start-upAgriloops lève 13M€ pour produire des gambas durables en France

Ne plus importer des dizaines de milliers de tonnes de gambas de l'autre bout du monde et en produire en Bretagne grâce à une technologie inédite, c'est le rêve des fondateurs d'Agriloops. Et, avec leur nouvelle levée de 13millions, ce rêve pourrait un jour devenir réalité.

Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy

The next wave of gene editing advances will likely center not only on efficacy but on the diversity of where the therapies can be delivered, and Genentech is signing a new deal to keep up with the | Roche is the latest large pharma to buy into GenEdit's nanoparticle delivery tech for gene editing therapies, paying $15 million upfront. The biotech previously added Eli Lilly as an investor and inked a partnership with Sarepta.

Merck & Co. signs $220M macrocyclic peptide deal after hailing ‘next wave of drug discovery’

Months after hailing macrocyclic peptides as the “next wave of drug discovery,” Merck & Co. | Months after hailing macrocyclic peptides as the “next wave of drug discovery,” Merck & Co. has pushed further into the space by penning a $220 million biobucks deal with Unnatural Products.